These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3114331)

  • 1. Proposed relation between expression of interleukin-2 and transferrin receptors in B lymphocyte chronic lymphocytic leukaemia.
    Barnett D; Wilson GA; Lawrence AC; Buckley GA
    J Clin Pathol; 1987 Jul; 40(7):814. PubMed ID: 3114331
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of functional interleukin 2 receptors on chronic lymphocytic leukaemia B lymphocytes is modulated by recombinant interleukin 2.
    Murphy JJ; Malkovska V; Hudson L; Millard RE
    Clin Exp Immunol; 1987 Oct; 70(1):182-91. PubMed ID: 3121222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoregulatory T-cell defects in B-cell chronic lymphocytic leukemia: cause or consequence of the disease? The contributory role of decreased availability of interleukin 2 (IL-2).
    Foa R; Fierro MT; Giovarelli M; Lusso P; Benetton G; Bonferroni M; Forni G
    Blood Cells; 1987; 12(2):399-412. PubMed ID: 2887225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-2 receptors on activated malignant and normal B-cells.
    Waldmann TA; Goldman CK; Leonard WJ; Depper JM; Robb RJ; Korsmeyer SJ; Greene WC
    Curr Top Microbiol Immunol; 1984; 113():96-101. PubMed ID: 6236954
    [No Abstract]   [Full Text] [Related]  

  • 5. New trends in the biology of B-chronic lymphocytic leukemia.
    Caligaris-Cappio F; Bergui L; Tesio L
    Haematologica; 1986; 71(2):91-4. PubMed ID: 3087838
    [No Abstract]   [Full Text] [Related]  

  • 6. Soluble interleukin-2 receptors in B-cell leukemia and the acquired immunodeficiency syndrome.
    Medina-Ibarrondo C; Lahuerta-Palacios JJ; Lahuerta-Palacios M
    Ann Intern Med; 1987 May; 106(5):774. PubMed ID: 3105379
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanisms underlying T-lymphocyte activation: mitogen initiates and IL-2 amplifies the expression of transferrin receptors via intracellular iron level.
    Pelosi-Testa E; Samoggia P; Giannella G; Montesoro E; Caravita T; Salvo G; Camagna A; Isacchi G; Testa U; Peschle C
    Immunology; 1988 Jun; 64(2):273-9. PubMed ID: 3134296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell membrane fluidity in chronic lymphocytic leukemia (CLL) lymphocytes and its relation to membrane receptor expression.
    Daefler S; Krueger GR; Mödder B; Deliconstantinos G
    J Exp Pathol; 1987; 3(2):147-54. PubMed ID: 2961855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cellular deficiency in the rheumatoid one-way mixed lymphocyte reaction.
    Salmon M; Bacon PA
    Clin Exp Immunol; 1988 Jan; 71(1):79-84. PubMed ID: 2964958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
    Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
    J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surface markers of T and B lymphocytes: I. General view and acute lymphoblastic leukaemia (ALL) (author's transl)].
    Tomić BL
    Lijec Vjesn; 1980 Nov; 102(11):643-6. PubMed ID: 7024694
    [No Abstract]   [Full Text] [Related]  

  • 12. Interleukin 2: its role in the proliferation of neoplastic T and B cells.
    Löwenberg B; Touw IP
    J Pathol; 1986 May; 149(1):15-21. PubMed ID: 3088238
    [No Abstract]   [Full Text] [Related]  

  • 13. Normal and certain leukaemic B cells express IL-2 receptors without in vitro activation.
    Armitage RJ; Cawley JC
    Clin Exp Immunol; 1986 Feb; 63(2):298-302. PubMed ID: 3009062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Visualization of IL2 and IL2 receptor in leprous dermal granulomata].
    Elageul B; Wallach D; Cottenot E
    Acta Leprol; 1986; 4(3):343-4. PubMed ID: 3551471
    [No Abstract]   [Full Text] [Related]  

  • 15. B cell differentiation and interleukin 2 (IL2): corticosteroids interact with monocytes to enhance the effect of IL2.
    Emilie D; Karray S; Crevon MC; Vazquez A; Galanaud P
    Eur J Immunol; 1987 Jun; 17(6):791-5. PubMed ID: 3109924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separation of T lymphocytes from normal individuals and patients with B lymphocyte chronic lymphocytic leukaemia.
    Fernandez LA; MacSween JM; Langley GR
    Immunology; 1975 Feb; 28(2):231-41. PubMed ID: 1091543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversibility of loss of homing receptor expression following activation.
    Jung TM; Dailey MO
    Adv Exp Med Biol; 1988; 237():519-24. PubMed ID: 3075863
    [No Abstract]   [Full Text] [Related]  

  • 18. [Interleukin 2 receptor positive B cells and its responsiveness to human recombinant interleukin 2 in patients with systemic lupus erythematosus].
    Matsumoto Y; Itoh A
    Rinsho Byori; 1987 Jun; 35(6):679-83. PubMed ID: 3118081
    [No Abstract]   [Full Text] [Related]  

  • 19. [The influences of serum IgE-specific suppressor factor (IgE-TsF), interleukin-2(IL-2), and interleukin-2 receptor (IL-2R) by hyposensitization to children with bronchial asthma].
    Liu WJ; Chiang CH; Huang TY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1988 Jun; 4(6):364-71. PubMed ID: 3136250
    [No Abstract]   [Full Text] [Related]  

  • 20. The multichain interleukin-2 receptor: from the gene to the bedside.
    Waldmann TA
    Harvey Lect; 1986-1987; 82():1-17. PubMed ID: 3129378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.